Results 131 to 140 of about 80,394 (203)

Incidence and Spatial Mapping of Tuberculosis and Multidrug-Resistant Tuberculosis in Libreville, Republic of Gabon, in 2022. [PDF]

Trop Med Infect Dis
Manzengo C, Ngatu NR, Manguinga-Guitouka S, Lignenguet F, Nkone-Asseko G, Nsimba-Miezi M, Miyatake N, Lami-Nzunzu J, Hirao T.   +8 more
europepmc   +1 more source

Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes. [PDF]

Microorganisms
Cebisa M, Dlatu N, Hosu MC, Apalata T, Faye LM.   +4 more
europepmc   +1 more source

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024. [PDF]

Open Forum Infect Dis
Liang R, Brust JCM, Reed C, Escuyer V, Armstrong DT, Parrish N, Valois P, Rowlinson MC, Marinova-Petkova A, Bisson GP, Labuda SM, Colon-Semidey A, Haley CA, Ashkin D, Peloquin CA, Lardizabal A, Patrawalla A, Cuenca A, Haas MK, Brostrom R, Mbakwem C, Schechter MC, Ray SM, Cummins J, Cahill B, Arn K, Chen LL, Wilson JW, Goswami ND.   +28 more
europepmc   +1 more source

Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort study. [PDF]

Lancet Reg Health Eur
Meier SC, Kukša L, Ķauķe S, Riekstina V, Biraua E, Jain N, Lange C, Brehm TT.   +7 more
europepmc   +1 more source

Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort. [PDF]

BMJ Open
Boois L, Ekandjo H, Shavuka O, Nepolo E, Ndong Sima CA, Oelofse C, Uren C, Petersen DC, Möller M, Wijk M, Kellermann T, Decloedt E, McIlleron H, Denti P, Claassens MM.   +14 more
europepmc   +1 more source

Quality of life scores using SF-12 and SF-36v2 questionnaires for patients with multidrug-resistant tuberculosis in Vietnam. [PDF]

Health Qual Life Outcomes
Ha NTL, Hoa NB, Yapa M, Anh NT, Li Q, Dang VH, Fox GJ, Dat VQ.   +7 more
europepmc   +1 more source

Tuberculosis transmission and resistance among Ukrainian migrants and its impact on multidrug-resistant tuberculosis dynamics in high-influx host countries. [PDF]

BMC Microbiol
Dohál M, Konstantynovska O, Hromádková M, Štrba M, Doležalová K, Wallenfels J, Porvazník I, Mäsiarová S, Krivošová M, Rasmussen EM, Kunč P, Hnilicová J, Solovič I, Mokrý J, Barilar I, Niemann S, Diricks M, Dvořáková V.   +17 more
europepmc   +1 more source

Improving Treatment Adherence in Youths With Multidrug-Resistant Tuberculosis With Psychosocial Intervention. [PDF]

Brain Behav
Dhumal G, Nevrekar N, Gupte N, Shrisunder R, Kulkarni P, Sarpotdar S, Pm A, Hosmani A, Lokhande R, Gupta A, Suryavanshi N.   +10 more
europepmc   +1 more source

Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration. [PDF]

Microbiol Spectr
Cheng J, Li J, Zheng R, Xu K, Ma X, Qiu J, Zhang R, Cai X.   +7 more
europepmc   +1 more source

Educational Level Mediates the Relationship Between Knowledge and Preventive Practices in Multidrug-Resistant Tuberculosis Patients. [PDF]

Epidemiologia (Basel)
Guardia Zuñiga RC, Abad de Vite BV, Azañero Suarez A, Espino Carrasco DK, García Santos E, Lajo Aquise IE, Cachay Sánchez I.   +6 more
europepmc   +1 more source